Skip to main content
. 2022 Dec 30;11(1):84. doi: 10.3390/vaccines11010084

Table 5.

Proportion of participants, without anti-spike antibody before vaccination, who developed COVID-19 antibody after vaccination (n = 99).

COVID-19 Antibody Time of Specimen Collection (Days)
After the First Dose 60 Days after Second Dose 150 Days after Second Dose 270 Days after Second Dose
Anti-Spike antibody (%) 94 (95) 99 (100) 99 (100) 99 (100)
Neutralising antibody (%) 46 (46.5) 61 (61.6) 54 (54.5) 73 (73.4)